News
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will present 16 abstracts featuring new data across its approved cancer therapies at the 2025 American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback